Cirrus ready for serialisation pack changesCirrus, a Multi Packaging Solutions company, offers a full artwork management service ahead of enforced pack changes due to impending legislation. The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require many companies to apply serialisation codes to their packaging. As a consequence, artwork changes will be required which all too often are treated as a rushed after-thought.
Gill Wright, Design & Development Director, Cirrus, explained: "The World Health Organisation estimates that around 50% of product recalls are still attributed to artwork errors and mislabelling. It is essential that all brand-owners consider the required changes in good time. Pharmaceutical artwork is a specialist market and any supplier’s workflow should be compliant with PS9000 / ISO9001, audited and dedicated to providing an artwork service. Artwork creation is often complex and selecting the right partner prevents damaging hard-earned reputations, product recall…or even putting patient's lives at risk."
The impending legislation will affect many different products especially those sold in multiple markets. Gill continued: "The first step to comply with this legislation is to get your artwork amended and approved. It is essential you know that your artwork is in safe hands."